AI-generated summary
The authors randomized 90 women with fibromyalgia to photobiomodulation combined with a static magnetic field or to placebo, over nine sessions across three weeks. They report fewer tender points in the active group than in placebo at the end of treatment and at four-week follow-up, with no adverse events reported. The abstract describes this as a single-center trial.
- Participants
- 90
- Who or what was studied
- Ninety female patients with fibromyalgia
- Limits stated in the abstract
- The abstract describes a single-center trial and does not report the wavelengths or treatment parameters used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on minervamedica.it.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Fibromyalgia, Photobiomodulation, Placebo-controlled, Low-level laser therapy, Primary outcome, Phototherapy, Blinding. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.